MAIA Biotechnology CEO Vlad Vitoc's 2022 pay jumps 72% to $1.2M
MAIA Biotechnology reports 2022 executive compensation
By ExecPay News
Published: April 19, 2023
MAIA Biotechnology reported fiscal year 2022 executive compensation information on April 19, 2023.
In 2022, four executives at MAIA Biotechnology received on average a compensation package of $891K, a 17% decrease compared to previous year.
Average pay of disclosed executives at MAIA Biotechnology
Vlad Vitoc, Chief Executive Officer, received $1.2M in total, which increased by 72% compared to 2021. 41% of Vitoc's compensation, or $492K, was in option awards. Vitoc also received $237K in bonus, $443K in salary, as well as $37K in other compensation.
Mihail Obrocea, Chief Medical Officer, received a compensation package of $851K, which decreased by 60% compared to previous year. 46% of the compensation package, or $391K, was in salary.
Sergei Gryaznov, Chief Scientific Officer, earned $771K in 2022, a 34% increase compared to previous year.
Joseph F. McGuire, Chief Financial Officer, received $734K in 2022, which decreases by 16% compared to 2021.
Related executives
You may also like
Source: SEC filing on April 19, 2023.